HomeVideoIt's All About-Charitable Organization-Sioux Falls-Researching Type 1 Diabetes

It's All About-Charitable Organization-Sioux Falls-Researching Type 1 Diabetes



Go to http://donetetosave.jdrftype1.com
Media Credits list http://broadcaster.beazil.net/public/credits/youtube/videos/43235 Type 1 diabetes is an auto-immune condition in which the immune system is activated to destroy the cells in the pancreas which produce insulin. We do not know what causes this auto-immune reaction. Type 1 diabetes is not linked to modifiable lifestyle factors. There is no cure and it cannot be prevented.
Type 1 diabetes:
– Occurs when the pancreas does not produce insulin
– Represents around 10% of all cases of diabetes and is one of the most common chronic childhood conditions
– Onset is usually abrupt and the symptoms obvious
– Symptoms can include excessive thirst and urination, unexplained weight loss, weakness and fatigue and blurred vision
– Is managed with insulin injections several times a day or the use of an insulin pump.
Sioux Falls has more than 70 parks and greenways. Probably the best known is Falls Park, established around the city’s namesake waterfalls on the Big Sioux River, just north of downtown. Other notable parks include Terrace Park, McKennan Park, Sherman Park, and Yankton Trail park. A popular feature of the park system is a paved 16-mile (26 km) path used for biking, jogging, and walking. The path follows the course of the Big Sioux River, forming a loop around Sioux Falls, along with a few spurs off the main bike trail. Recently, the city stepped up efforts to beautify a stretch of the bike trails through downtown along an area known as the River Greenway. Currently, two out of three planned phases of construction and updates have occurred. The Health Care and Social Assistance industry includes establishments and services such as:
hospitals, nursing and residential care facilities and out-patient care centres; offices of health practitioners (i.e. dentists, doctors, optometrists and chiropractors); medical and diagnostic laboratories; home health care services; ambulance services; social assistance services (i.e. for children, youth, the elderly, families); community food, housing, emergency and relief services; vocational rehabilitation services; and daycare services JDRF is the only organization with a strategic research plan to end T1D. Our strategies include: Artificial Pancreas Systems Artificial pancreas systems will eliminate blood glucose testing and carb counting by totally automating insulin dosing, initially preventing dangerous low blood sugars and eventually ensuring ideal glucose control. Complications JDRF’s complications research is leading to therapies to treat and even reverse some of the debilitating, costly, and life-threatening complications caused by T1D. Encapsulation JDRF’s encapsulation research will restore insulin independence for 18 months to two years
by implanting newly created beta cells into a protective capsule, which eliminates the need for toxic immune suppression therapies. JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
View our blog page http://jdrf.org/blog/
See more at https://plus.google.com/110620633690555176280/
Join us at our YouTube channel https://www.youtube.com/user/jdrfonline
Go to our Facebook account https://www.facebook.com/myJDRF
Check our Twitter account https://twitter.com/JDRFTypeOne
See more at https://www.linkedin.com/company/jdrf
Subscribe at our Instagram account https://www.instagram.com/jdrfadvocacy/
Join us at our Pinterest account https://www.pinterest.com/jdrfadvocacy/
Here are the main points of the mentioned above:
oral hypoglycemic agents,Afrezza,noninsulin monotherapy,transplantation insulin-secreting cells,prevention of complications,Clinical Trials,Type 2 Diabetes,Tuthill Park,The Automation to Simulate Pancreatic Insulin Response Trial,Wall Drug,turn Type One into Type Now,storing insulin,Team Cure Diabetes,diabetic ketoacidosis,mean glucose,Robert Wood Johnson IV,Neuropathy,Research,Artificial Pancreas,interstitial glucose,TRIAD Results,symptoms of T1D,Children’s Congress,SMBG,glycemic control comparison,advocating for government support,latent autoimmune diabetes in adults,life-changing breakthroughs,Glucagon-like peptide 1 agonists,T1DLooksLikeMe,treatment of diabetes,Clinicians,hyperglycemia,premixed insulin,Insulin,Managing a hypo,six international.

source

Previous post
It's Time For-Charity Organization-Arcadia-Researching Type 1 Diabetes
Next post
How To/Nonprofit Foundation/Redondo Beach/Type None Diabetes

Leave a Reply

Be the First to Comment!

Notify of
avatar
wpDiscuz